Crohn's disease exclusion diet as an add-on to antitumor necrosis factor-α therapy in children with moderate-to-severe Crohn's disease
- PMID: 40926602
- DOI: 10.1002/jpn3.70208
Crohn's disease exclusion diet as an add-on to antitumor necrosis factor-α therapy in children with moderate-to-severe Crohn's disease
Keywords: biological therapies; inflammatory bowel diseases; whole‐food nutritional therapy.
References
REFERENCES
-
- Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359(9317):1541‐1549.
-
- Hyams JS, Griffiths A, Markowitz J, et al. Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterology. 2012;143(2):365‐374.e2.
-
- van Rheenen PF, Aloi M, Assa A, et al. The medical management of paediatric Crohn's disease: an ECCO‐ESPGHAN guideline update. J Crohns Colitis. 2020;15:jjaa161.
-
- Levine A, Wine E, Assa A, et al. Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019;157(2):440‐450.e8.
-
- Scarallo L, Banci E, Pierattini V, Lionetti P. Crohn's disease exclusion diet in children with Crohn's disease: a case series. Curr Med Res Opin. 2021;37(7):1115‐1120.
Grants and funding
LinkOut - more resources
Full Text Sources
